Chakraborty's research focuses on sexual and reproductive health. Overarching themes in Chakraborty's writings include a focus on reproductive autonomy through ensuring that individuals have the resources, support, and agency to enact their reproductive health choices, with a specific emphasis on impacts of existing structures and policies, as well as proposed legislation, on sexual and reproductive health outcomes. Chakraborty is a Graduate Research Associate with the Ohio Policy Evaluation Network, and is Treasurer of the Public Health Graduate Student Association.
In the News
Discusses how among reproductive-aged women in Ohio, legislative and judicial activities around Ohio's 6-week abortion ban was associated with increased percentages of women believing abortion to be illegal. Clarifies that Ohio lawmaker's attempts to restrict abortion in the state could lead to women believing that abortion is illegal, even when when unsuccessful.
Mentions in the US in 2017, an average of 8% of patients left their state of residence to access abortion care. Shows state-level abortion policy and scarcity of abortion facilities are associated with cross-state travel to obtain abortion care.
Examines abortion utilization in Ohio from 2010 to 2018 when about 15 laws restricting abortion went into effect. Reveals abortion policies co-occur with later abortions, suggesting delays to abortion care. Restrictive policies also increase geographic inequities, especially in rural areas.
Establishes about a quarter of adult reporductive aged women in Ohio reported not using their preferred contraceptive method in 2018–2019. Mentions affordability and poor provider satisfaction related to contraceptive care were associated with not using one's preferred contraceptive method.
Studies how travel distance to abortion care would be impacted if any of three of Ohio's proposed abortion bans go into effect in a post-Roe context. Stresses distance for Ohioans would increase dramatically from an average of 26 miles as of February 2022 to 157 miles in a best case post-Roe scenario or 269 miles in a worst-case scenario.
Shows the REMS on mifepristone is a barrier to expansion of medication and telemedicine abortion services in OH, KY, and WV, but lifting of the REMS alone would not expand access to medication abortion because of other state restrictions.